Pharmacokinetic and pharmacodynamic evaluation of P-873 versus Klebsiella pneumoniae in a neutropenic murine thigh infection model

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1971-1973

  Lamb, Lucinda M ^a   Crandon, Jared L ^a   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; P 873; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG POTENCY; DRUG SCREENING; FEMALE; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANIMALS; FEMALE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; NEUTROPENIA; PROTEIN SYNTHESIS INHIBITORS; THIGH;

EID: 84875193036     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02170-12     Document Type: Article

References (8)

1. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. 2008. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Disease Society of America. Clin. Infect. Dis. 46:155-164.
2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Disease Society of America. Clin. Infect. Dis. 48:1-12.
3. Bhattacharjee A, Chen S, Collin F, Dalton J, DeVito J, Kanyo Z, Leggio M, Lou R, Martynow J, O'Dowd H, Paik I, Remy J, Scheideman M, Sinishtaj S, Tang Y, Wimberly B, Wu Y, Duffy E. 2011. Completely novel antibiotics for treating multidrug-resistant Gram-negative infections: the pyrrolocytosines, abstr F1-1846. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
4. Marra A, Bortolon E, Molstad D, Wu Y, Jing H, Duffy E. 2011. Novel ribosome inhibitors are efficacious in a murine skin and soft tissue infection model caused by Klebsiella pneumoniae, abstr F1-1853. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
5. Jacobs MR, Bajaksouzian S, Windau AR, Foster AN, Hujer KM, Bonomo RA. 2012. Activity of novel pyrrolocytosine agents against multidrug and carbapenem resistant Klebsiella pneumoniae, abstr F-2059. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
6. Bortolon E, Molstad D, DelGorge C, Rey A, Duffy E. 2012. Novel ribosome inhibitors are efficacious in a murine respiratory tract infection model caused by Streptococcus pneumoniae, abstr F-1523. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
7. Bulik CC, Nicolau DP. 2010. In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemaseproducing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54: 4112-4115.
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI publication M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.